Concepedia

Deepa Rangachari

DR

40

Publications

2.3K

Citations

24

H-Index

2015

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Dana-Farber Cancer Institute

Massachusetts General Hospital

Johns Hopkins University

Deepa Rangachari is an author at Beth Israel Deaconess Medical Center specializing in lung cancer, oncology, and medicine.

Top concepts

MedicineOncologyLung CancerPathologyRadiation OncologyCancer TherapyTumor BiologyCancer GeneticsMolecular OncologyMolecular Diagnostics

Publications per year

2015–2024

40

Publications

40

Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

Deepa Rangachari, Norihiro Yamaguchi, Paul A. VanderLaan et al. · Lung Cancer · 2015 · 509 citations · Full text

Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer

Anna F. Farago, Beow Y. Yeap, Marcello Stanzione et al. · Cancer Discovery · 2019 · 231 citations · Full text

Mutations in TP53 , PIK3CA , PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes

Paul A. VanderLaan, Deepa Rangachari, Susan M. Mockus et al. · Lung Cancer · 2017 · 207 citations · Full text

Lung Cancers, Oncology, Medicine +11

Correlation between Classic Driver Oncogene Mutations in EGFR , ALK , or ROS1 and 22C3–PD-L1 ≥50% Expression in Lung Adenocarcinoma

Deepa Rangachari, Paul A. VanderLaan, Meghan Shea et al. · Journal of Thoracic Oncology · 2017 · 126 citations · Full text

Tumor Biology, Oncology, Medicine +10

Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non–Small Cell Lung Cancer

Lorena Ostios-García, Jennifer Faig, Giulia C. Leonardi et al. · Journal of Thoracic Oncology · 2018 · 91 citations · Full text

Oncology, Immunology, Pd-1 Inhibitors +10

Rows per page

1–5 of 40